Robotic Ankle Assistance + Audiovisual Biofeedback for Cerebral Palsy
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants should not have had botulinum toxin injections in the prior 3 months.
What data supports the effectiveness of the treatment Robotic Ankle Assistance + Audiovisual Biofeedback for Cerebral Palsy?
Research shows that biofeedback, including visual and auditory forms, can improve walking patterns in children with cerebral palsy by enhancing step length and ankle movement. Studies also indicate that combining biofeedback with robotic ankle assistance can further enhance walking performance, suggesting this treatment may be effective for improving gait in children with cerebral palsy.12345
Is the Robotic Ankle Assistance with Audiovisual Biofeedback safe for humans?
How is the treatment 'Gait Adaptation and Biofeedback' unique for cerebral palsy?
This treatment is unique because it combines robotic ankle assistance with real-time audiovisual biofeedback to improve walking patterns in children with cerebral palsy. Unlike traditional therapies, it uses technology to provide immediate feedback on gait parameters like step length and ankle power, helping to enhance walking performance and symmetry.12367
What is the purpose of this trial?
This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.
Research Team
Katherine M Steele, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for children with bilateral cerebral palsy affecting both legs, who can walk but have some limitations (GMFCS Level II). They shouldn't have had leg surgery or injuries in the last year, botulinum toxin injections in the past 3 months, prior selective dorsal rhizotomy surgery, seizures or heart conditions that limit treadmill use, or current pain impacting walking.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 6-8 weeks of multimodal biofeedback training or orthopedic surgery
Follow-up
Participants are monitored for changes in gait and adaptation rates after treatment
Open-label extension (optional)
Participants may continue to receive feedback training to further enhance walking function
Treatment Details
Interventions
- Audiovisual Biofeedback
- Biomotum Spark: Robotic ankle resistance
- Gait Adaptation and Biofeedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Gillette Children's
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Gillette Children's Specialty Healthcare
Collaborator
Northern Arizona University
Collaborator